Recent BioUtah News & Events

Renowned African Swine Fever Researcher, Douglas Gladue, PhD, joins Seek Labs as Vice President of Veterinary Pharmaceutical Development

ELITechGroup continues to expand its portfolio of IVDR-certified PCR assays to support European diagnostic laboratories

The Thermo Scientific™ Stellar™ mass spectrometer combines speed and sensitivity to advance precision medicine.

START is a pilot program newly launched jointly by the FDA CDER and CBER divisions to further accelerate the development of novel drug and biological products for rare diseases

FIVE-YEAR DATA SHOW EXCELLENT OUTCOMES FOR FEMALE AND SMALL ANNULUS PATIENTS WITH EDWARDS TAVR

Owlet presented at the TD Cowen 8th Annual Future of the Consumer Conference 2024.

Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool

Nomi’s payment infrastructure shortens Tellus’ payment cycle from as much as 30-60 days to just one day.

Agreement strengthens Edwards’ strategy to advance structural heart innovation.

Turner Imaging announced a significant milestone as they celebrate the sale of their 300th SMART-C system to the Surgical Center of Greensboro.

Gov. Cox this week toured Teva Pharmaceuticals, Stryker, and ARUP Laboratories to see firsthand the life-changing technology and innovation taking place in Utah’s dynamic life sciences community. Following the facility tours, Cox held on-site town halls to engage with employees. He applauded the industry’s mission to improve and save lives and noted that the sector […]

SOUTH SAN FRANCISCO, Calif and SALT LAKE CITY, May 28, 2024 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq:LAB) today announced that it has purchased the LSAXT system from Carterra®, a leading provider of high-throughput large and small molecule screening and characterization solutions. This instrument will enable Standard BioTools™ to further validate its SomaScan® Platform by measuring the […]

Published open-access today in Nature Genetics, “High-resolution genome-wide mapping of chromosome-arm-scale truncations induced by CRISPR–Cas9 editing” identifies novel evidence of a proximity bias in CRISPR-Cas9 gene knockouts and a debiasing (correcting) algorithm.

First patient, first visit is planned for early June 2024

SERA PROGNOSTICS EXPECTED TO BE ADDED TO RUSSELL 2000 AND 3000 INDEXES

A new campus building will place the University of Utah at the forefront of medical device innovation.

Malawi Ministry of Health, bioMérieux, and Pfizer Form Country’s First Multisectoral Collaboration to Help Address Antimicrobial Resistance

New investment drives development of advanced AI tools for mental health care screening and monitoring

The UCLA research team created a low cost and customizable lipid nanoparticle using “click chemistry” for precise targeting of cancer cell surface markers

These three U.S. cities are putting themselves on the biotech map as unsung hubs of the industry.

Versatile analog device offers fast inflation and ease of use, streamlining patient care

PolarityTE Secures $22.5 Million Financing to Advance SkinTE Phase III Pivotal Study in Diabetic Foot Ulcers

Study to Evaluate SOR102, a Novel Oral Dual-Acting Antibody Targeting TNF⍺ and IL-23 (p19) for Inflammatory Bowel Disease

Major Milestone for EVŌQ Nano’s Biotech Arm Targeting Antibiotic-Resistant Bacterial Infections Linked to Cystic Fibrosis and Other Lung Diseases   SALT LAKE CITY, Utah, (May 15, 2024) — EVŌQ Bio, a wholly-owned subsidiary of EVŌQ Nano, today announced the successful completion of a Pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) […]